S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
NYSE:PATH

UiPath (PATH) Stock Forecast, Price & News

$16.29
-0.03 (-0.18%)
(As of 09/22/2023 ET)
Compare
Today's Range
$16.19
$16.55
50-Day Range
$14.57
$19.18
52-Week Range
$10.40
$19.94
Volume
5.32 million shs
Average Volume
7.87 million shs
Market Capitalization
$9.23 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.84

UiPath MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
21.8% Upside
$19.84 Price Target
Short Interest
Bearish
10.52% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.56mentions of UiPath in the last 14 days
Based on 13 Articles This Week
Insider Trading
Selling Shares
$3.07 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.28) to ($0.27) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.08 out of 5 stars

Business Services Sector

158th out of 307 stocks

Prepackaged Software Industry

110th out of 199 stocks


PATH stock logo

About UiPath (NYSE:PATH) Stock

UiPath Inc. is a leading software company specializing in robotic process automation (RPA) technology. Headquartered in New York City, but founded in Bucharest, Romania, UiPath offers a comprehensive platform that automates repetitive tasks and enables businesses to operate more efficiently. The company was founded in 2005 by Romanian entrepreneurs Daniel Dines and Marius Tirca and has since grown to become a significant player in the RPA industry. UiPath has received numerous awards and accolades, including being named a leader in the Gartner Magic Quadrant for RPA Software in 2020.

UiPath's executive team is led by Chief Executive Officer and co-founder Daniel Dines, who has been with the company since its inception. Daniel is considered one of the pioneers of robotic process automation, helping start the industry. Mr. Dines contributes to his success in the industry by being relentless and constantly exposing himself to the industry's uncertainties. Other key management team members include Chief Financial Officer Ashim Gupta and Chief Marketing Officer Bobby Patrick. In 2021, UiPath announced that former Microsoft executive Tom Clancy would join as its new Senior Vice President of Learning.

UiPath has experienced significant growth in recent years, with revenue increasing exponentially since its inception. The company's net loss has been decreasing yearly. As of January 31, 2021, UiPath has cash, cash equivalents, and short-term investments capable of covering liabilities indicating that the company is working to keep control of its debt. UiPath's valuation has fluctuated since its IPO, with the company's market capitalization reaching a high of over $45 billion in May 2021 before falling to around $10 billion in Q4 of 2022. UiPath's price-to-sales ratio is higher than the industry average. Since its IPO in April 2021, UiPath's stock price has been volatile, with shares reaching a high of $90 in May 2021 before dropping to around $10 in November 2022. Since hitting its all-time low price, the stock has rebounded. Trading volume has also been relatively high, with an average of over 6 million shares traded per day.

The robotic process automation industry has experienced rapid growth in recent years as businesses seek to automate manual processes and increase efficiency. UiPath competes with several other robotic process automation providers, including Automation Anywhere, Blue Prism, and WorkFusion. In addition, the industry is subject to regulatory and political pressures, particularly around data privacy and security.

UiPath has identified several critical areas for growth, including expanding its product offerings to include artificial intelligence and machine learning capabilities and targeting new industries such as healthcare and financial services. The company has also been actively pursuing acquisitions, with recent purchases including Cloud Elements and ProcessGold.

As the robotic process automation industry continues to evolve, UiPath may face challenges from competitors who can offer similar or better technology at a lower cost. In addition, regulatory and political pressures may create uncertainty for the industry, which could impact UiPath's growth prospects.

PATH Price History

PATH Stock News Headlines

Institutions Make Big Bets On AI Stocks With Profits (PATH)
2 Leading AI Stocks Going Opposite Ways (PATH)
Artificial intelligence (AI) has driven the new enterprise demand cycle for servers, services and applications; some companies are meeting demand, some are not
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
The Top 5 Analysts Calls in September  (PATH)
These stocks have more in common than analysts' attention. Read on to find out why these are the Most Upgraded Stocks for the 1st week of September.
AI 2.0 is Here: How to Invest in a Generational Opportunity (PATH)
AI is sweeping the world but don't confuse apples with oranges; here's a look at the top 5 advancements in AI and who is using it.
The Top 5 Robot Stocks Automating Investment Returns Now (PATH)
AI is hot and nowhere hotter than the applications that use it, including physical and software robots that automate business processes.
7 Best Robotics Stocks to Buy Now (PATH)
What are the best robotics stocks to buy now, as AI continues to influence many sectors? Learn more about the best robotics stocks to buy now with MarketBeat.
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
UiPath (NYSE:PATH) vs. SAP (NYSE:SAP) Financial Review
UiPath: Slowly Building A Position Is A Great Strategy
UiPath: The Real AI Pioneer
Better AI Stock: C3.ai vs. UiPath
See More Headlines
Receive PATH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for UiPath and its competitors with MarketBeat's FREE daily newsletter.

PATH Company Calendar

Last Earnings
9/06/2023
Today
9/22/2023
Next Earnings (Estimated)
12/07/2023
Fiscal Year End
1/31/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Fax
N/A
Employees
3,833
Year Founded
2005

Price Target and Rating

Average Stock Price Forecast
$19.84
High Stock Price Forecast
$27.50
Low Stock Price Forecast
$16.00
Forecasted Upside/Downside
+21.8%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
15 Analysts

Profitability

Net Income
$-328,350,000.00
Pretax Margin
-14.66%

Debt

Sales & Book Value

Annual Sales
$1.06 billion
Book Value
$3.50 per share

Miscellaneous

Free Float
390,879,000
Market Cap
$9.23 billion
Optionable
Not Optionable
Beta
0.69

Social Links

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Daniel Solomon Dines (Age 51)
    Co-Founder, Co-CEO & Chairman
    Comp: $771.84k
  • Mr. Robert Enslin (Age 60)
    Co-Chief Exec. Officer
    Comp: $1.29M
  • Mr. Ashim GuptaMr. Ashim Gupta (Age 44)
    Chief Financial Officer
    Comp: $799.57k
  • Mr. Brad C. BrubakerMr. Brad C. Brubaker (Age 59)
    Gen. Counsel, Chief Legal Officer & Sec.
    Comp: $663.85k
  • Hitesh RamaniHitesh Ramani
    Chief Accounting Officer
  • Ms. Kelsey Doherty Turcotte
    Sr. VP of Investor Relations
  • Mr. Robert B. Patrick (Age 51)
    Chief Marketing Officer
  • Mr. Vijay Khanna
    Chief Corp. Devel. Officer
  • Ms. Brigette McInnis-Day
    Chief People Office
  • Mr. Munil Shah
    Chief Technology Officer of Automation Cloud













PATH Stock - Frequently Asked Questions

Should I buy or sell UiPath stock right now?

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for UiPath in the last twelve months. There are currently 9 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PATH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PATH, but not buy additional shares or sell existing shares.
View PATH analyst ratings
or view top-rated stocks.

What is UiPath's stock price forecast for 2023?

15 brokers have issued 1 year price objectives for UiPath's shares. Their PATH share price forecasts range from $16.00 to $27.50. On average, they predict the company's share price to reach $19.84 in the next twelve months. This suggests a possible upside of 21.8% from the stock's current price.
View analysts price targets for PATH
or view top-rated stocks among Wall Street analysts.

How have PATH shares performed in 2023?

UiPath's stock was trading at $12.71 at the beginning of the year. Since then, PATH shares have increased by 28.2% and is now trading at $16.29.
View the best growth stocks for 2023 here
.

When is UiPath's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, December 7th 2023.
View our PATH earnings forecast
.

How were UiPath's earnings last quarter?

UiPath Inc. (NYSE:PATH) released its quarterly earnings results on Wednesday, September, 6th. The healthcare company reported $0.09 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.05. The healthcare company earned $287.31 million during the quarter, compared to analysts' expectations of $281.48 million. UiPath had a negative trailing twelve-month return on equity of 7.49% and a negative net margin of 15.47%. The business's revenue for the quarter was up 18.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.18) earnings per share.

What guidance has UiPath issued on next quarter's earnings?

UiPath updated its third quarter 2024 earnings guidance on Wednesday, September, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $313.00 million-$318.00 million, compared to the consensus revenue estimate of $315.33 million.

When did UiPath IPO?

(PATH) raised $990 million in an initial public offering on Wednesday, April 21st 2021. The company issued 21,300,000 shares at a price of $43.00-$50.00 per share. Morgan Stanley, JPMorgan, BofA Securities, Credit Suisse, Barclays and Wells Fargo Securities acted as the underwriters for the IPO and SMBC Nikko, BMO Capital Markets, Mizuho Securities USA, KeyBanc Capital Markets, TD Securities (USA), Truist SecuritiesCowen, Evercore Group, Macquarie Capital (USA), Nomura, RBC Capital Markets, Canaccord Genuity, D. A. Davidson & Co., Oppenheimer & Co. and Needham & Co. were co-managers.

What is UiPath's stock symbol?

UiPath trades on the New York Stock Exchange (NYSE) under the ticker symbol "PATH."

Who are UiPath's major shareholders?

UiPath's stock is owned by many different institutional and retail investors. Top institutional shareholders include ARK Investment Management LLC (8.60%), Sumitomo Mitsui Trust Holdings Inc. (4.68%), BlackRock Inc. (4.17%), Goldman Sachs Group Inc. (2.08%), Accel Growth Fund IV Associates L.L.C. (1.33%) and State Street Corp (1.32%). Insiders that own company stock include Ashim Gupta, Brad Brubaker, Daniel Dines, East Fund 2013 Sca Sic Digital, Hitesh Ramani, Kimberly Hammonds, Laela Sturdy, Philippe Botteri, Rich Wong, Ted Kummert and Thomas Neergaard Hansen.
View institutional ownership trends
.

How do I buy shares of UiPath?

Shares of PATH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is UiPath's stock price today?

One share of PATH stock can currently be purchased for approximately $16.29.

How much money does UiPath make?

UiPath (NYSE:PATH) has a market capitalization of $9.23 billion and generates $1.06 billion in revenue each year. The healthcare company earns $-328,350,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis.

How many employees does UiPath have?

The company employs 3,833 workers across the globe.

Does UiPath have any subsidiaries?
The following companies are subsidiares of UiPath: Cloud Elements, Cloud Elements Inc., CloudElements Technologies India Private Limited, MagnaView BV, ProcessGold A.G., ProcessGold B.V., ProcessGold International B.V., Re:infer, Shanghai Zhicheng Technology Co. Ltd., StepShot, The Conundrum IP LLC, UiPath AB, UiPath Australia Pty Ltd, UiPath Austria GmbH, UiPath Belgium BVBA, UiPath Brasil Consultoria Limitada, UiPath Business Solutions India Private Limited, UiPath Canada Operations Ltd., UiPath Denmark ApS, UiPath Finland Oy, UiPath France SAS, UiPath GMBH, UiPath Inc., UiPath Israel LTD, UiPath Italy SRL, UiPath Kabushiki Kaisha, UiPath Korea Ltd., UiPath Limited (Hong Kong), UiPath Ltd. (UK), UiPath Mexico S. DE R.L. DE C.V., UiPath Netherlands B.V., UiPath Netherlands Holding B.V., UiPath Norway AS, UiPath OOO, UiPath PTE LTD, UiPath Process Mining, UiPath Robotic Process Automation India Private Limited, UiPath SRL, UiPath South Africa (Pty) LTD, UiPath Switzerland GmbH, UiPath Ukraine LLC, and UiPath Ventures LLC.
Read More
How can I contact UiPath?

UiPath's mailing address is 7 Great Valley Pkwy Ste 300, MALVERN, PA 19355-1425, United States. The official website for the company is www.uipath.com. The healthcare company can be reached via phone at 844-432-0455 or via email at investor.relations@uipath.com.

This page (NYSE:PATH) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -